Utilizing Molecular Modeling to Guide Biotherapeutics Formulation

Time: 11:45 am
day: Day Two


  • Intravenous vs. subcutaneous: Story of the first oncology mAb and need for high concentration formulation
  • Where and how in silico modeling can help biotherapeutics formulation? Risk assessment; protein-protein interactions; virtual excipient screening
  • Opportunities and future directions to expand the usage of modeling in biologics drug product development